Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Medtronic
Harvard Business School
Express Scripts
Moodys

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Apotex Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has two hundred and twenty-one approved drugs.

There are sixteen tentative approvals on APOTEX INC drugs.

Drugs and US Patents for Apotex Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc LETROZOLE letrozole TABLET;ORAL 091303-001 Apr 19, 2012 AB RX No No   Start Trial   Start Trial
Apotex Inc OLOPATADINE HYDROCHLORIDE olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 090918-001 Dec 5, 2017 AT RX No No   Start Trial   Start Trial
Apotex Inc MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206135-002 Nov 22, 2016 AB RX No No   Start Trial   Start Trial
Apotex Inc BROMFENAC SODIUM bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 202435-001 Jun 19, 2014 DISCN No No   Start Trial   Start Trial
Apotex Inc RAMIPRIL ramipril TABLET;ORAL 091069-001 Dec 2, 2015 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for APOTEX INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Harvard Business School
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.